Lata Medical Research Foundation, Nagpur
15
2
2
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
27%
4 trials in Phase 3/4
25%
2 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries
Role: collaborator
Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
Role: collaborator
Caffeine for Hypoxic Ischemic Encephalopathy
Role: collaborator
Trial of the Use of Antenatal Corticosteroids in Developing Countries
Role: collaborator
Azithromycin-Prevention in Labor Use Study (A-PLUS)
Role: collaborator
Prevention of Iron Deficiency Anemia Post-delivery
Role: collaborator
Malaria In Pregnancy in Central India
Role: lead
Diabetes In Sindhi Families In Nagpur (DISFIN)
Role: lead
Mobile -Solutions Aiding Knowledge for Health Improvement
Role: lead
Use of Mobile Phones for Thermal Imaging of the Chest to Save Lives of Children With Pneumonia in Nagpur, India
Role: collaborator
Simplified Gestational Age Score
Role: collaborator
Global Network Implementation of Helping Babies Breathe (HBB)
Role: collaborator
IndiaCLEN Multicentre Trial of Home Versus Hospital Oral Amoxicillin for Management of Severe Pneumonia in Children
Role: lead
Use of the Camouflage Syringe to Reduce Dental Anxiety and Fear in Children
Role: collaborator
Evaluation of Effectiveness of Cell Phone Technology as Community Based Intervention to Improve Exclusive Breast Feeding
Role: lead
All 15 trials loaded